Latest News

Moderna Stock Jumps After Earnings Trounce Estimates

Moderna stock was rallying after a big earnings beat.

Eugene Hoshiko/POOL/AFP via Getty Images

Text size


Moderna

stock was jumping after the maker of a Covid-19 vaccine’s earnings crushed analyst estimates.

Moderna reported a profit of $8.58 a share, easily topping analyst estimates for a profit of $5.37, on revenue of $6 billion, trouncing forecasts for $4.204 billion.

“The Moderna team delivered a strong Q1 performance and I am thankful for the progress our team continues to make as we advance our pipeline of mRNA medicines,” Moderna CEO Stéphane Bancel said in a press release.

Moderna stock has gained 5.3% in premarket trading Wednesday morning. Its shares have fallen 42% in 2022, more than three times the

S&P 500’s
12% decline.

Moderna recently said it would have its Covid vaccine for children under the age of six ready for FDA review by June.

Write to Ben Levisohn at ben.levisohn@barrons.com

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News